Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Patients with cerebral venous thrombosis (CVT) treated with dabigatran or warfarin experienced low rates of recurrent venous thrombotic events (VTEs). Both anticoagulants demonstrated similar safety profiles regarding bleeding risk, suggesting efficacy in preventing VTE recurrence.
Area Of Science
- Neurology
- Cardiology
- Hematology
Background
- Cerebral venous thrombosis (CVT) patients face a significant risk of recurrent venous thrombotic events (VTEs).
- Non-vitamin K oral anticoagulants (NOACs) have not been extensively studied in randomized trials for CVT management.
- Evaluating novel anticoagulants is crucial for optimizing secondary prevention in CVT.
Purpose Of The Study
- To compare the efficacy and safety of dabigatran etexilate versus dose-adjusted warfarin in preventing recurrent VTEs in patients with a history of CVT.
- To assess the rates of recurrent VTEs and major bleeding in patients treated with either dabigatran or warfarin.
Main Methods
- RE-SPECT CVT was a prospective, randomized, open-label, multicenter trial involving 120 adult patients with acute CVT.
- Patients received either dabigatran (150 mg twice daily) or dose-adjusted warfarin for 24 weeks.
- The primary outcome was a composite of new VTE or major bleeding; secondary outcomes included cerebral venous recanalization.
Main Results
- No recurrent VTEs were observed in either treatment group.
- Major bleeding occurred in 1.7% of patients on dabigatran and 3.3% on warfarin.
- Cerebral venous recanalization rates were comparable: 60.0% for dabigatran and 67.3% for warfarin.
Conclusions
- Dabigatran and warfarin appear to be safe and effective options for preventing recurrent VTEs in patients with CVT.
- Both anticoagulants showed a low risk of recurrent VTEs and similar bleeding profiles.
- Further research may confirm these findings and guide long-term anticoagulation strategies for CVT.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Here, we present a protocol for a study comparing the efficacy, safety, and delivery of olive-oil-based 3CB and soybean-oil-based CoB formulations in adults requiring parenteral nutrition. The results revealed that olive-oil-based 3CBs is non-inferior and well tolerated compared to soybean...
This article aims to present an optimized method for assessing venous thrombosis in a mouse cancer model, using vascular clips to achieve venous ligation. Optimization minimizes variability in thrombosis-related measurements and enhances relevance to human cancer-associated venous...
Here, we present a protocol to analyze the effectiveness and safety of Angong Niuhuang Pill in the treatment of viral...
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Traditionally, lower extremity deep venous thrombosis (DVT) is diagnosed by radiology-performed venous duplex ultrasound. Providers appropriately trained in focused point-of-care ultrasound (POCUS) can perform a rapid bedside examination with high sensitivity and specificity in critically ill patients. We describe the scanning technique for focused POCUS DVT lower extremity...